Researchers presented a first study on biological pathways perturbed in association with CRCI, anxiety, and co-occurring CRCI.

Incidence of RTOME is 5.83 percent in patients with head and neck cancer, with significant variation seen by cancer type.

The rate of appropriate treatment suggestions was 86.6% for Claude3-Opus, 85.7% for GPT4-Turbo, and 75.0% for LLaMa3-70B. Artificial intelligence (AI) can accurately suggest appropriate adjuvant ...